TY - JOUR
T1 - The Role of Arginine in Thrombin Receptor Tethered-Ligand Peptide in Intramolecular Receptor Binding and Self-Activation
AU - Nose, Takeru
AU - Satoh, Yusuke
AU - Fujita, Tsugumi
AU - Ohno, Motonori
AU - Nakajima, Masahide
AU - Inoue, Yoshihisa
AU - Ogino, Yoshio
AU - Costa, Tommaso
AU - Shimohigashi, Yasuyuki
PY - 1998/7
Y1 - 1998/7
N2 - Synthetic heptapeptide of the human thrombin receptor tethered-ligandpeptide, H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-NH2 (SFLLRNP), activates fully the thrombin receptor without thrombin. The functional role of Arg-5 was examined using a series of analogs having amino acid substitutions at position 5 in this assays was to assess the abilities to hydrolyze phosphoinositide in human neuroblastoma SH-EP cells and to aggregate the human platelet. The replacement of Arg-5 by Ala reduced the activity (9% activity of the parent peptide) in the Pl-turnover assay, and abolished completely the platelet aggregation activity. SFLL/Lys/NP was also active, but moderately; 36% in PI-turnover and 12% in platelet aggregation. These results indicated that the electrostatic interaction of the Arg-guanidino group is important for a peptide to interact with the receptor. When citrulline or glutamine was placed at position 5 instead of arginine, the resulting SFLL/citrulline/NP and SFLL/Gln/NP were found to be potent in both assays. Since citrulline and glutamine possess a side chain which can serve as hydrogen donor and/or acceptor, the receptor ctivation of these peptides appears to be due to hydrogen bonding at this position. The molecular mechanisms to explain both electrostatic and hydrogen-bonding interactions were postulated based on the structural modeling of seven-transmembrane domain thrombin receptor.
AB - Synthetic heptapeptide of the human thrombin receptor tethered-ligandpeptide, H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-NH2 (SFLLRNP), activates fully the thrombin receptor without thrombin. The functional role of Arg-5 was examined using a series of analogs having amino acid substitutions at position 5 in this assays was to assess the abilities to hydrolyze phosphoinositide in human neuroblastoma SH-EP cells and to aggregate the human platelet. The replacement of Arg-5 by Ala reduced the activity (9% activity of the parent peptide) in the Pl-turnover assay, and abolished completely the platelet aggregation activity. SFLL/Lys/NP was also active, but moderately; 36% in PI-turnover and 12% in platelet aggregation. These results indicated that the electrostatic interaction of the Arg-guanidino group is important for a peptide to interact with the receptor. When citrulline or glutamine was placed at position 5 instead of arginine, the resulting SFLL/citrulline/NP and SFLL/Gln/NP were found to be potent in both assays. Since citrulline and glutamine possess a side chain which can serve as hydrogen donor and/or acceptor, the receptor ctivation of these peptides appears to be due to hydrogen bonding at this position. The molecular mechanisms to explain both electrostatic and hydrogen-bonding interactions were postulated based on the structural modeling of seven-transmembrane domain thrombin receptor.
UR - http://www.scopus.com/inward/record.url?scp=0000917381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0000917381&partnerID=8YFLogxK
U2 - 10.1246/bcsj.71.1661
DO - 10.1246/bcsj.71.1661
M3 - Article
AN - SCOPUS:0000917381
SN - 0009-2673
VL - 71
SP - 1661
EP - 1665
JO - Bulletin of the Chemical Society of Japan
JF - Bulletin of the Chemical Society of Japan
IS - 7
ER -